BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7772251)

  • 1. SV40 T antigen directed by a powerful erythroid enhancer-promoter produced sarcomas and pancreatic tumors but not erythroid-specific tumors in transgenic mice.
    Teitz T; Yen TS; Chang JC; Kan YW
    DNA Cell Biol; 1994 Jul; 13(7):705-10. PubMed ID: 7772251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of a SV40 T antigen transgene is associated with sarcomagenesis in mice.
    Teitz T; Yen TS; Kan YW
    Carcinogenesis; 1994 Sep; 15(9):2049-51. PubMed ID: 7923601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.
    Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH
    Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected and coordinated expression of Spi-1, Fli-1, and megakaryocytic genes in four Epo-dependent cell lines established from transgenic mice displaying erythroid-specific expression of a thermosensitive SV40 T antigen.
    Starck J; Mouchiroud G; Gonnet C; Mehlen A; Aubert D; Dorier A; Godet J; Morlé F
    Exp Hematol; 1999 Apr; 27(4):630-41. PubMed ID: 10210321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene.
    Teitz T; Chang JC; Kitamura M; Yen TS; Kan YW
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2910-4. PubMed ID: 7681991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic epithelial neoplasms in transgenic mice expressing SV40 T antigen under the control of an erythroid-specific enhancer.
    Teitz T; Chang JC; Kan YW; Yen TS
    J Pathol; 1995 Nov; 177(3):309-15. PubMed ID: 8551394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous sarcomas of probable neuronal origin in a transgenic mouse strain containing an albumin promoter-fused simian virus 40 large T antigen gene.
    Kawabuchi B; Nomura K; Ohtake K; Hino O; Aizawa S; Machinami R; Kitagawa T
    Jpn J Cancer Res; 1994 Jun; 85(6):601-9. PubMed ID: 8063613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a fusion gene consisting of the mouse growth hormone-releasing hormone gene promoter linked to the SV40 T-antigen gene in transgenic mice.
    Nogues N; Magnan E; De Grandis P; Butz M; Kineman RD; Kopchick JJ; Frohman LA
    Mol Cell Endocrinol; 1998 Feb; 137(2):161-8. PubMed ID: 9605518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of neuroepithelial tumors of the adrenal medulla in transgenic mice expressing a mouse hypothalamic growth hormone-releasing hormone promoter-simian virus-40 T-antigen fusion gene.
    Pecori Giraldi F; Mizobuchi M; Horowitz ZD; Downs TR; Aleppo G; Kier A; Wagner T; Yun JS; Kopchick JJ; Frohman LA
    Endocrinology; 1994 Mar; 134(3):1219-24. PubMed ID: 8119162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals.
    Santarelli R; Tzeng YJ; Zimmermann C; Guhl E; Graessmann A
    Oncogene; 1996 Feb; 12(3):495-505. PubMed ID: 8637705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumors of the retinal pigment epithelium metastasize to inguinal lymph nodes and spleen in tyrosinase-related protein 1/SV40 T antigen transgenic mice.
    Penna D; Schmidt A; Beermann F
    Oncogene; 1998 Nov; 17(20):2601-7. PubMed ID: 9840923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen.
    Theuring F; Götz W; Balling R; Korf HW; Schulze F; Herken R; Gruss P
    Oncogene; 1990 Feb; 5(2):225-32. PubMed ID: 2157185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen.
    Marcus DM; Lasudry JG; Carpenter JL; Windle J; Howes KA; al-Ubaidi MR; Baehr W; Overbeek PA; Font RL; Albert DM
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):392-6. PubMed ID: 8603844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.
    Gordon J; Del Valle L; Otte J; Khalili K
    Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-promoter SV40 large T-antigen transgenes induce tumors irrespective of normal cellular expression of renin genes.
    Sola C; Tronik D; Dreyfus M; Babinet C; Rougeon F
    Oncogene Res; 1989; 5(2):149-53. PubMed ID: 2558335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploid male germ cells show no susceptibility to transformation by simian virus 40 large tumour antigen in transgenic mice.
    Nayernia K; Samani AA; Klaproth S; Engel W
    Cell Biol Int; 1998; 22(6):437-43. PubMed ID: 10328852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smooth muscle and bone neoplasms in transgenic mice expressing SV40 T antigen.
    Wilkie TM; Schmidt RA; Baetscher M; Messing A
    Oncogene; 1994 Oct; 9(10):2889-95. PubMed ID: 8084593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene.
    Bell RH; Memoli VA; Longnecker DS
    Carcinogenesis; 1990 Aug; 11(8):1393-8. PubMed ID: 2167183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice.
    Perez-Stable C; Altman NH; Brown J; Harbison M; Cray C; Roos BA
    Lab Invest; 1996 Feb; 74(2):363-73. PubMed ID: 8780156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen.
    Soldevila G; Geiger T; Flavell RA
    J Immunol; 1995 Dec; 155(12):5590-600. PubMed ID: 7499842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.